APPROACH TO COLLABORATION Sample Clauses

APPROACH TO COLLABORATION. 4.1 The Parties agree to adopt the following approach to collaboration when commissioning, developing and procuring digital and information solutions (the “Approach to Collaboration”): 4.1.1 Address the vision. The Parties seek to establish arrangements where anything which is ‘place-based’, and, therefore, enables or has an impact on integrated services or care, will be decided upon a ‘Place First’ principle through a City Digital team. Where other economic opportunities might be identified that individual organisations can choose to opt-in or out of, thus benefitting the use of the Leeds, West Yorkshire or National ‘£’. Overall providing integrated solutions and delivering best value for the taxpayer and operating a financially sustainable system; 4.1.2 Collaborate and co-operate. Establish and adhere to the governance structure set out in this MoA to ensure that activities are delivered and actions taken as required to deliver change collectively and in partnership with each other and the wider Health and Care System nationally, regionally and locally; 4.1.3 Be accountable. Take on, manage and account to each other, the wider LHCP area population for performance of the respective roles and responsibilities set out in this MoA, the Leeds Informatics Board will review performance against this MoA; 4.1.4 Be open and transparent and act with integrity. Communicate openly with each other about major concerns, issues or opportunities relating to digital and information strategy. 4.1.5 Adhere to statutory requirements and best practice. Comply with applicable laws and standards including procurement rules, competition law, data protection and freedom of information legislation; 4.1.6 Act in a timely manner. Recognise the time-critical nature of the City Digital Programme development and delivery and respond accordingly to requests for support; 4.1.7 Manage stakeholders effectively. Ensure communication and engagement both internally and externally is clear, coherent, consistent and credible and in line with the Parties’ statutory duties, values and objectives.
APPROACH TO COLLABORATION. 4.1 The Parties agree to adopt the following approach to collaboration when commissioning, developing and procuring digital and information solutions (the “Approach to Collaboration”): 4.1.1 Address the vision. The Parties seek to establish arrangements where anything which is ‘place-based’, and, therefore, enables or has an impact on integrated services or care, will be decided upon a ‘Place First’ principle through a City Digital team. Where other economic opportunities might be identified that individual organisations can choose to opt-in or out of, thus benefitting the use of the Leeds, West Yorkshire or National ‘£’. Overall providing integrated solutions and delivering best value for the taxpayer and operating a financially sustainable system; 4.1.2 Collaborate and co-operate. Establish and adhere to the governance structure set out in this MoA to ensure that activities are delivered and actions taken as required to deliver change collectively and in partnership with each other and the wider Health and Care System nationally, regionally and locally; 4.1.3 Be accountable. Take on, manage and account to each other, the wider Leeds and Health Care Partnership area population for performance of the respective roles and responsibilities set out in this MoA; 4.1.4 Be open and transparent and act with integrity. Communicate openly with each other about major concerns, issues or opportunities relating to digital and information strategy and comply with the seven Principles of Public Life established by the ▇▇▇▇▇ Committee (the ▇▇▇▇▇ Principles) and where appropriate the NHS Foundation Trust Code of Governance (as issued by Monitor and updated in July 2014) including implementing a transparent and explicit approach to the declaration and handling of relevant and material conflicts of interests arising. 4.1.5 Adhere to statutory requirements and best practice. Comply with applicable laws and standards including procurement rules, competition law, data protection and freedom of information legislation; 4.1.6 Act in a timely manner. Recognise the time-critical nature of the City Digital Programme development and delivery and respond accordingly to requests for support; 4.1.7 Manage stakeholders effectively. Ensure communication and engagement both internally and externally is clear, coherent, consistent and credible and in line with the Parties’ statutory duties, values and objectives.
APPROACH TO COLLABORATION. The technical plan for the Collaboration is outlined in Appendix A. Overall, the plan is focused on the development and validation of ***. In the spirit of an open and mutually productive Collaboration, it is expected that both parties will exchange ideas freely to advance the project. Both parties shall agree to share with one another all knowledge and information relating to the Collaboration, including *** evaluation methodologies and experimental results. Notwithstanding the foregoing, each party shall comply with its existing confidentiality obligations to third parties.

Related to APPROACH TO COLLABORATION

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Scope of Collaboration As part of the collaboration, the Controllers will act as Joint Controller. The roles of the Controller and the associated tasks are specified in more detail in Appendix 1. If one party is solely responsible for a data processing operation, this party will implement all relevant data protection provisions on its own responsibility. However, such data processing procedures are not subject to this Agreement. Joint data processing and the type of Personal Data collected and processed within the framework of collaboration are specified in Appendix 1.

  • Collaboration activities 4.1 The Collaboration Suppliers will perform the Collaboration Activities and all other obligations of this Agreement in accordance with the Detailed Collaboration Plan. 4.2 The Collaboration Suppliers will provide all additional cooperation and assistance as is reasonably required by the Buyer to ensure the continuous delivery of the services under the Call-Off Contract. 4.3 The Collaboration Suppliers will ensure that their respective subcontractors provide all cooperation and assistance as set out in the Detailed Collaboration Plan.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).